These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20619975)

  • 1. Susceptibility of rapidly growing mycobacteria isolated from cats and dogs, to ciprofloxacin, enrofloxacin and moxifloxacin.
    Govendir M; Hansen T; Kimble B; Norris JM; Baral RM; Wigney DI; Gottlieb S; Malik R
    Vet Microbiol; 2011 Jan; 147(1-2):113-8. PubMed ID: 20619975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
    Govendir M; Norris JM; Hansen T; Wigney DI; Muscatello G; Trott DJ; Malik R
    Vet Microbiol; 2011 Dec; 153(3-4):240-5. PubMed ID: 21726965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
    Bennie CJ; To JL; Martin PA; Govendir M
    Aust Vet J; 2015; 93(1-2):40-5. PubMed ID: 25622709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
    Boothe DM; Boeckh A; Simpson RB; Dubose K
    J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of rapidly growing mycobacteria isolated from Australian cats to ivermectin, moxidectin, ceftiofur and florfenicol.
    Woerde DJ; Martin PA; Govendir M
    J Feline Med Surg; 2015 Dec; 17(12):1065-8. PubMed ID: 25572306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
    Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
    Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings.
    Malik R; Wigney DI; Dawson D; Martin P; Hunt GB; Love DN
    J Feline Med Surg; 2000 Mar; 2(1):35-48. PubMed ID: 11716590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R; Cockrum P; Crider J; Schlech B
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan.
    Hatakeyama S; Ohama Y; Okazaki M; Nukui Y; Moriya K
    BMC Infect Dis; 2017 Mar; 17(1):197. PubMed ID: 28270102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
    Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
    J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
    Liu X; Boothe DM; Jin Y; Thungrat K
    World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
    Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus.
    Lee SY; Fan HW; Sutherland C; DeRyke AC; Nicolau DP
    Drugs R D; 2007; 8(2):69-77. PubMed ID: 17324004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapidly growing members of the genus Mycobacterium affecting dogs and cats.
    Jang SS; Hirsh DC
    J Am Anim Hosp Assoc; 2002; 38(3):217-20. PubMed ID: 12022405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
    Proksch JW; Ward KW
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of
    Brown Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0007921. PubMed ID: 33846136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
    Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
    Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.